Navigating DLBCL Treatment Strategies for Patients Experiencing Resistance to Therapy
In his closing thoughts, Dr Gordon discusses navigation of treatment resistance in DLBCL management.
Read More
Additional Treatment Strategies and Collaborative Care for Patients with DLBCL
The impact of collaborative care in DLBCL treatment is explored by a medical expert.
DLBCL Treatment in Elderly Patients with Multiple Comorbidities
Treatment of DLBCL amid comorbidities in elderly patients is highlighted.
Utilizing Bispecific Treatment in Relapsed DLBCL Patients
Dr Gordon discusses use of bispecifics for management of patients with relapsing DLBCL.
High-Level Toxicities Associated with DLBCL Treatment
Dr Gordon provides strategies for navigating treatment-associated toxicities in DLBCL management as directed by NCCN Guidelines.
Progressive Treatment Strategies for DLBCL Directed by NCCN Guidelines
A medical expert examines first6, second-, and third-line systemic therapies for DLBCL in accordance with NCCN Guidelines.
Key Updates in NCCN Guidelines Surrounding DLBCL Treatment
Key recommendations and recent updates in the latest version of NCCN guidelines for DLBCL are outlined by Dr Gordon.
Overview of B-Cell Lymphoma-Related NCCN Guideline Development
Leo Gordon, MD, provides an overview of current treatment strategies currently driven by NCCN guidelines.
